# Mood Disorders in Head and Neck Cancer Patients

> **NCT04977271** · PHASE4 · WITHDRAWN · sponsor: **University of Alabama at Birmingham**

## Conditions studied

- Depressive Disorder
- Head and Neck Cancer

## Interventions

- **DRUG:** Venlafaxine

## Key facts

- **NCT ID:** NCT04977271
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-01-05
- **Primary completion:** 2024-10-01
- **Final completion:** 2024-10-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** study never opened
- **Last updated:** 2025-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04977271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04977271, "Mood Disorders in Head and Neck Cancer Patients". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04977271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*